Search - tctmd.com

Displaying 21 - 40 of 176

Sort: Relevancy | Date

News Daily News

Care Gaps for Women With Cardiogenic Shock Merit Action: SCAI

L.A. McKeown

June 05, 2025

News Daily News

Benefits of SGLT2 Inhibitors for HF Affirmed in Large, Real-world Study

Todd Neale

May 09, 2025

News Daily News

STRONG-HF Analysis Quantifies Gains From Rapid Uptake of GDMT

Todd Neale

May 08, 2025

News Daily News

AHA Statement Zeroes In On Sleep Health

L.A. McKeown

April 17, 2025

News Daily News

Mavacamten Strikes Out in Phase III Trial of Nonobstructive HCM

L.A. McKeown

April 15, 2025

News Daily News

Some Mitral TEER Patients Slipping Through the Cracks in the First Month

Michael O'Riordan

March 21, 2025

News Daily News

Vutrisiran, With the FDA’s Sign-off, Joins the Fray for ATTR-CM

Caitlin E. Cox

March 21, 2025

News Daily News

REVIVED/STICHES Analysis Questions Surgery’s Benefit in Ischemic HF

Michael O'Riordan

March 11, 2025

News Daily News

Finerenone Cuts Intensification of Oral Diuretics in Outpatient Setting: FINEARTS-HF

Michael O'Riordan

March 03, 2025

News Daily News

Sotagliflozin Reduces Ischemic Risk in SCORED Analysis

Yael L. Maxwell

February 25, 2025

News Daily News

Even on Tafamidis, ATTR-CM Patients Face High Mortality Over Time

Michael O'Riordan

February 13, 2025

News Daily News

Acoramidis Approved in Europe for ATTR Cardiomyopathy

Michael O'Riordan

February 12, 2025

News Daily News

Vascular Disease History Need Not Preclude Aspirin Withdrawal After HeartMate 3

Yael L. Maxwell

January 15, 2025

News Daily News

Change in Kidney Function With Finerenone Doesn’t Impact Treatment’s Benefit

Michael O'Riordan

January 13, 2025

News Daily News

Top Heart Failure News of 2024

Todd Neale

December 31, 2024

News Daily News

FINEARTS-HF Analysis Supports Finerenone’s Value in HFpEF With Obesity

L.A. McKeown

December 13, 2024

News Daily News

Rethinking the Evidence for ICDs for HFrEF in Light of Today’s GDMT

L.A. McKeown

December 05, 2024

News Daily News

FDA Approves First ‘Near-Complete’ Stabilizer to Treat ATTR Cardiomyopathy

L.A. McKeown

November 25, 2024

News Daily News

HFSA Stats 2024 a ‘Call to Action’ Against Rising Tide of HF

L.A. McKeown

October 01, 2024

News Daily News

HFSA Cancels Annual Meeting Due to Looming Hurricane

L.A. McKeown

September 26, 2024

Advertisement

Care Gaps for Women With Cardiogenic Shock Merit Action: SCAI

Benefits of SGLT2 Inhibitors for HF Affirmed in Large, Real-world Study

STRONG-HF Analysis Quantifies Gains From Rapid Uptake of GDMT

AHA Statement Zeroes In On Sleep Health

Mavacamten Strikes Out in Phase III Trial of Nonobstructive HCM

Some Mitral TEER Patients Slipping Through the Cracks in the First Month

Vutrisiran, With the FDA’s Sign-off, Joins the Fray for ATTR-CM

REVIVED/STICHES Analysis Questions Surgery’s Benefit in Ischemic HF

Finerenone Cuts Intensification of Oral Diuretics in Outpatient Setting: FINEARTS-HF

Sotagliflozin Reduces Ischemic Risk in SCORED Analysis

Even on Tafamidis, ATTR-CM Patients Face High Mortality Over Time

Acoramidis Approved in Europe for ATTR Cardiomyopathy

Vascular Disease History Need Not Preclude Aspirin Withdrawal After HeartMate 3

Change in Kidney Function With Finerenone Doesn’t Impact Treatment’s Benefit

Top Heart Failure News of 2024

FINEARTS-HF Analysis Supports Finerenone’s Value in HFpEF With Obesity

Rethinking the Evidence for ICDs for HFrEF in Light of Today’s GDMT

FDA Approves First ‘Near-Complete’ Stabilizer to Treat ATTR Cardiomyopathy

HFSA Stats 2024 a ‘Call to Action’ Against Rising Tide of HF

HFSA Cancels Annual Meeting Due to Looming Hurricane

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content